Peer-reviewedCC BY-NC 4.0BMJ Open
Evaluation of methodology, reporting and transparency of 50 highly cited randomised trials in neurology: a cross-sectional analysis
- 1Institute for Evidence in Medicine, Medical Center - University of Freiburg, Freiburg, Germany
- 2Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany
Related
- Design, reporting, and research focus of neurology and psychiatry drug trials (2020–2023): a registry-based meta-epidemiological study using ClinicalTrials.gov and NLP
- Early Exposure to Neonatal Neurology and Cranial Ultrasound: A Pilot Evaluation of an Undergraduate Course
- Reporting Randomised Trials of Physical Exercise or Training Interventions in Older Adults
- Reporting of justifications for withholding established effective interventions in randomised placebo-controlled trials: a systematic review.
- An Evaluation of the Guidelines for Premature Rupture of Membranes Based on the Appraisal of Guidelines for Research and Evaluation II, the Scientific, Transparent, and Applicable Rankings, and the Reporting Items for Practice Guidelines in Health Care Methods
BibTeX
@article{benkendorff2026evaluation,
title = {{Evaluation of methodology, reporting and transparency of 50 highly cited randomised trials in neurology: a cross-sectional analysis}},
author = {Alexander Benkendorff and Elida Sina and Anneke Clara Bergt and Julia Stadelmaier and Joerg J Meerpohl},
journal = {BMJ Open},
year = {2026},
month = oct,
doi = {10.1136/bmjopen-2026-117895},
url = {https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-117895},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Evaluation of methodology, reporting and transparency of 50 highly cited randomised trials in neurology: a cross-sectional analysis
AU - Alexander Benkendorff
AU - Elida Sina
AU - Anneke Clara Bergt
AU - Julia Stadelmaier
AU - Joerg J Meerpohl
PY - 2026
DA - 2026/10/09
JO - BMJ Open
DO - 10.1136/bmjopen-2026-117895
UR - https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-117895
SN - 2044-6055
SN - 2044-6055
ER -